Key result
The newer-generation (G4) MitraClip TEER system offered a safer procedure with lower postprocedural TMPG, mediating a reduced HF rehospitalization risk (proportion mediated 1.8%; P=0.016).
Why the study?
Comparative data on early- (G2) versus newer-generation (G4) MitraClip TEER systems remain limited.
Does the newer-generation (G4) MitraClip TEER system improve procedural and clinical outcomes compared to the early-generation (G2) system in patients with degenerative or functional mitral regurgitation?
Observational (n=3,738)
Does the newer-generation (G4) MitraClip TEER system improve procedural and clinical outcomes compared to the early-generation (G2) system in patients with degenerative or functional mitral regurgitation?
Effect estimate: 1.8% proportion mediated
p-value: p=0.016
The newer-generation G4 MitraClip system provides safer and more efficient procedures with lower postprocedural TMPG and reduced HF rehospitalization risk compared to the G2 system.
BACKGROUND: Comparative data on early- (G2) vs newer-generation (G4) MitraClip transcatheter edge-to-edge repair (TEER) systems remain limited. OBJECTIVES: The authors compared procedural and clinical outcomes of both devices in patients with degenerative mitral regurgitation (DMR) or functional mitral regurgitation (FMR). METHODS: Using the OCEAN (Optimized Catheter Valvular Intervention)-Mitral registry, 3,738 patients undergoing TEER with either G2 (n = 1,481) or G4 (n = 2,257) MitraClips were analyzed. Outcomes included procedural metrics, echocardiographic parameters, and clinical events. RESULTS: < 0.001). A causal mediation analysis revealed that postprocedural TMPG modestly mediated the association between device generation and HF rehospitalization risk (proportion mediated = 1.8% [Q1-Q3: 0.3%-4.0%]; P = 0.016). CONCLUSIONS: The newer-generation TEER system offers a safer and more efficient procedure, with shorter procedural time, fewer mechanical complications, fewer clips, and a lower postprocedural TMPG, contributing to reduced HF rehospitalization risk, particularly in DMR.
No takes yet. Share an insight, caveat, or question.
Okuno et al. (2025) conducted an observational in Degenerative or functional mitral regurgitation (n=3,738). Newer-generation (G4) MitraClip vs. Early-generation (G2) MitraClip was evaluated on Heart failure rehospitalization risk (1.8% proportion mediated, p=0.016). The newer-generation (G4) MitraClip TEER system offered a safer procedure with lower postprocedural TMPG, mediating a reduced HF rehospitalization risk (proportion mediated 1.8%; P=0.016).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: